Financial Freedom LLC’s iShares Biotechnology ETF IBB Stock Holding History

Financial Freedom LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-101	Closed	-$17K	–	233
2026 Q1	$17K	Hold	101	–	–	0.01%	253
2025 Q4	$17K	Hold	101	–	–	0.01%	237
2025 Q3	$14.5K	Hold	101	–	–	0.01%	252
2025 Q2	$12.7K	Hold	101	–	–	0.01%	255
2025 Q1	$12.9K	Sell	101 -74	-42%	-$10K	0.01%	259
2024 Q4	$23.2K	Hold	175	–	–	0.01%	207
2024 Q3	$25.5K	Hold	175	–	–	0.01%	199
2024 Q2	$24.1K	Hold	175	–	–	0.01%	206
2024 Q1	$24.1K	Hold	175	–	–	0.01%	208
2023 Q4	$23.8K	Hold	175	–	–	0.02%	205
2023 Q3	$21.4K	Buy	175 +100	+133%	+$12.7K	0.02%	208
2023 Q2	$9.52K	Hold	75	–	–	0.01%	282
2023 Q1	$9.69K	Hold	75	–	–	0.01%	273
2022 Q4	$9.85K	Buy	+75	New	+$9.69K	0.01%	269

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Financial Freedom LLC's IBB Position: Q2 2026 in Review

Financial Freedom LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 101 shares — an estimated $17K sold.

Financial Freedom LLC first reported a position in IBB in Q4 2022 and held it in 14 quarters. The position peaked at $25.5K in Q3 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Financial Freedom LLC reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
Financial Freedom LLC sold 101 iShares Biotechnology ETF shares in Q2 2026, an estimated $17K.
Financial Freedom LLC first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 14 quarters.
Financial Freedom LLC's iShares Biotechnology ETF position peaked at $25.5K in Q3 2024.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.